Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats

Neuropsychopharmacology

Volumn 36, Issue 5, 2011, Pages 1114-1125

  Schneider, Tomasz ^a,c   Ilott, Nicholas ^a   Brolese, Giovana ^b   Bizarro, Lisiane ^b   Asherson, Philip J E ^a   Stolerman, Ian P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ADHD; attention; dopamine system; gestation; impulsivity; nicotine

Indexed keywords

DOPAMINE 5 RECEPTOR; MESSENGER RNA; NICOTINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DEVELOPMENTAL DISORDER; FEMALE; FETUS OUTCOME; GENE OVEREXPRESSION; GRIP STRENGTH; LEARNING; LOCOMOTION; LOW BIRTH WEIGHT; MALE; NONHUMAN; POSTNATAL DEVELOPMENT; POSTNATAL GROWTH; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; REACTION TIME; SENSORIMOTOR FUNCTION; SMOKING; STIMULUS RESPONSE; TASK PERFORMANCE; VISUAL STIMULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CHOICE BEHAVIOR; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE EXPRESSION REGULATION; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NICOTINIC AGONISTS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOMOTOR PERFORMANCE; RATS; REACTION TIME; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5; REFLEX;

EID: 79952767811     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.249     Document Type: Article

References (87)

1. Adams J (1986). Methods in Behavioral Teratology. Plenum Press: New York pp 67-97.
2. Ajarem JS, Ahmad M (1998). Prenatal nicotine exposure modifies behavior of mice through early development. Pharmacol Biochem Behav 59: 313-318. (Pubitemid 28072722)
3. Andreou P, Neale BM, Chen W, Christiansen H, Gabriels I, Heise A et al (2007). Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects. Psychol Med 37: 1703-1715. (Pubitemid 350100437)
4. Antrop I, Roeyers H, Van Oost P, Buysse A (2000). Stimulation seeking and hyperactivity in children with ADHD. Attention Deficit Hyperactivity Disorder. J Child Psychol Psychiatry 41: 225-231. (Pubitemid 30150712)
5. Asherson P, Brookes K, Franke B, Chen W, Gill M, Ebstein RP et al (2007). Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry 164: 674-677. (Pubitemid 46650201)
6. Barkley RA, Edwards G, Laneri M, Fletcher K, Metevia L (2001). Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). J Abnorm Child Psychol 29: 541-556. (Pubitemid 33745788)
7. Bedard AC, Ickowicz A, Logan GD, Hogg-Johnson S, Schachar R, Tannock R (2003). Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. J Abnorm Child Psychol 31: 315-327. (Pubitemid 36626755)
8. Benowitz NL, Hukkanen J, Jacob III P (2009). Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 192: 29-60.
9. Bertolini A, Bernardi M, Genedani S (1982). Effects of prenatal exposure to cigarette smoke and nicotine on pregnancy, offspring development and avoidance behavior in rats. Neurobehav Toxicol Teratol 4: 545-548. (Pubitemid 13170064)
10. Burns MJ, Nixon GJ, Foy CA, Harris N (2005). Standardisation of data from real-time quantitative PCR methodsFevaluation of outliers and comparison of calibration curves. BMC Biotechnol 5: 31.
11. Cardinal RN (2006). Neural systems implicated in delayed and probabilistic reinforcement. Neural Netw 19: 1277-1301. (Pubitemid 44472601)
12. Casper RC (2004). Nutrients, neurodevelopment, and mood. Curr Psychiatry Rep 6: 425-429. (Pubitemid 41599915)
13. Castellanos FX (2001). Neural substrates of attention-deficit hyperactivity disorder. Adv Neurol 85: 197-206.
14. Cornelius MD, Day NL (2009). Developmental consequences of prenatal tobacco exposure. Curr Opin Neurol 22: 121-125.
15. D'Onofrio BM, Van Hulle CA, Waldman ID, Rodgers JL, Harden KP, Rathouz PJ et al (2008). Smoking during pregnancy and offspring externalizing problems: an exploration of genetic and environmental confounds. Dev Psychopathol 20: 139-164. (Pubitemid 351166710)
16. Durston S, Belle JV, Zeeuw PD (2010). Differentiating frontostriatal and fronto-cerebellar circuits in attention-deficit/hyperactivity disorder. Biol Psychiatry; e-pub ahead of print 19 October 2010; doi:10.1016/j.biopsych.2010. 07.037.
17. Dwyer JB, Broide RS, Leslie FM (2008). Nicotine and brain development. Birth Defects Res C Embryo Today 84: 30-44. (Pubitemid 351499891)
18. Epstein JN, Erkanli A, Conners CK, Klaric J, Costello JE, Angold A (2003). Relations between continuous performance test performance measures and ADHD behaviors. J Abnorm Child Psychol 31: 543-554. (Pubitemid 37229132)
19. Epstein JN, Johnson DE, Varia IM, Conners CK (2001). Neurop-sychological assessment of response inhibition in adults with ADHD. J Clin Exp Neuropsychol 23: 362-371. (Pubitemid 32579378)
20. Ernst M, Moolchan ET, Robinson ML (2001). Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 40: 630-641. (Pubitemid 32473376)
21. Eskenazi B, Prehn AW, Christianson RE (1995). Passive and active maternal smoking as measured by serum cotinine: the effect on birthweight. Am J Public Health 85: 395-398.
22. Evenden JL (1999). Varieties of impulsivity. Psychopharmacology (Berl) 146: 348-361. (Pubitemid 29513276)
23. Faraone SV, Biederman J, Mick E (2006). The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 36: 159-165. (Pubitemid 43126140)
24. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA et al (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 1313-1323. (Pubitemid 40798551)
25. Franke RM, Park M, Belluzzi JD, Leslie FM (2008). Prenatal nicotine exposure changes natural and drug-induced reinforcement in adolescent male rats. Eur J Neurosci 27: 2952-2961. (Pubitemid 351832215)
26. Fung YK (1989). Postnatal effects of maternal nicotine exposure on the striatal dopaminergic system in rats. J Pharm Pharmacol 41: 576-578. (Pubitemid 19214352)
27. Gianni ML, Picciolini O, Vegni C, Gardon L, Fumagalli M, Mosca F (2007). Twelve-month neurofunctional assessment and cognitive performance at 36 months of age in extremely low birth weight infants. Pediatrics 120: 1012-1019. (Pubitemid 350085534)
28. Gizer IR, Ficks C, Waldman ID (2009). Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 126: 51-90.
29. Greven U, Ronald A, Rodriguez A (2010). Non-shared environmental effects of birth weight on ADHD symptoms persist into early adolescence. A 10-year longitudinal twin study. Longit Life Course Stud 3(Suppl): 332.
30. Hack M (2006). Young adult outcomes of very-low-birth-weight children. Semin Fetal Neonatal Med 11: 127-137.
31. Hahn B, Shoaib M, Stolerman IP (2002). Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands. Psychopharmacology (Berl) 162: 129-137. (Pubitemid 34743952)
32. Jauniaux E, Burton GJ (2007). Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit. Early Hum Dev 83: 699-706. (Pubitemid 350018714)
33. Johansson S, Halleland H, Halmoy A, Jacobsen KK, Landaas ET, Dramsdahl M et al (2008). Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs. Am J Med Genet B Neuropsychiatr Genet 147B: 1470-1475.
34. Johnson KA, Wiersema JR, Kuntsi J (2009). What would Karl Popper say? Are current psychological theories of ADHD falsifiable? Behav Brain Funct 5: 15.
35. Klein C, Wendling K, Huettner P, Ruder H, Peper M (2006). Intra-subject variability in attention-deficit hyperactivity disorder. Biol Psychiatry 60: 1088-1097. (Pubitemid 44754856)
36. Kotimaa AJ, Moilanen I, Taanila A, Ebeling H, Smalley SL, McGough JJ et al (2003). Maternal smoking and hyperactivity in 8-year-old children. J Am Acad Child Adolesc Psychiatry 42: 826-833. (Pubitemid 39571846)
37. Kuntsi J, McLoughlin G, Asherson P (2006). Attention deficit hyperactivity disorder. Neuromolecular Med 8: 461-484. (Pubitemid 44547515)
38. Kuntsi J, Wood AC, Rijsdijk F, Johnson KA, Andreou P, Albrecht B et al (2010). Separation of cognitive impairments in attention deficit hyperactivity disorder into two familial factors. Arch Gen Psychiatry 67: 1159-1167.
39. LeSage MG, Gustaf E, Dufek MB, Pentel PR (2006). Effects of maternal intravenous nicotine administration on locomotor behavior in pre-weanling rats. Pharmacol Biochem Behav 85: 575-583. (Pubitemid 46097069)
40. Levin ED, Briggs SJ, Christopher NC, Rose JE (1993). Prenatal nicotine exposure and cognitive performance in rats. Neurotox-icol Teratol 15: 251-260. (Pubitemid 23233620)
41. Levin ED, Lawrence S, Petro A, Horton K, Seidler FJ, Slotkin TA (2006). Increased nicotine self-administration following prenatal exposure in female rats. Pharmacol Biochem Behav 85: 669-674. (Pubitemid 46097078)
42. Li D, Sham PC, Owen MJ, He L (2006). Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 15: 2276-2284. (Pubitemid 43994869)
43. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408. (Pubitemid 34164012)
44. Manor I, Corbex M, Eisenberg J, Gritsenkso I, Bachner-Melman R, Tyano S et al (2004). Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA). Am J Med Genet B Neuropsychiatr Genet 127B: 73-77. (Pubitemid 38542317)
45. Marco R, Miranda A, Schlotz W, Melia A, Mulligan A, Muller U et al (2009). Delay and reward choice in ADHD: an experimental test of the role of delay aversion. Neuropsychology 23: 367-380.
46. McDonald J, Schleifer L, Richards JB, De WH (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28: 1356-1365. (Pubitemid 41070907)
47. McLoughlin G, Ronald A, Kuntsi J, Asherson P, Plomin R (2007). Genetic support for the dual nature of attention deficit hyperactivity disorder: Substantial genetic overlap between the inattentive and hyperactive-impulsive components. J Abnorm Child Psychol 35: 999-1008. (Pubitemid 47476575)
48. Mill J, Petronis A (2008). Pre- and peri-natal environmental risks for attention-deficit hyperactivity disorder (ADHD): the potential role of epigenetic processes in mediating susceptibility. J Child Psychol Psychiatry 49: 1020-1030.
49. Misener VL, Luca P, Azeke O, Crosbie J, Waldman I, Tannock R et al (2004). Linkage of the dopamine receptor D1 gene to attention-deficit/ hyperactivity disorder. Mol Psychiatry 9: 500-509. (Pubitemid 38903506)
50. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC (2001). Psychiatric aspects of impulsivity. Am J Psychiatry 158: 1783-1793. (Pubitemid 33054770)
51. Muir JL, Everitt BJ, Robbins TW (1996). The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex 6: 470-481.
52. Muneoka K, Nakatsu T, Fuji J, Ogawa T, Takigawa M (1999). Prenatal administration of nicotine results in dopaminergic alterations in the neocortex. Neurotoxicol Teratol 21: 603-609. (Pubitemid 29415764)
53. Murrin LC, Ferrer JR, Zeng WY, Haley NJ (1987). Nicotine administration to rats: methodological considerations. Life Sci 40: 1699-1708. (Pubitemid 17055482)
54. Paloyelis Y, Asherson P, Kuntsi J (2009). Are ADHD symptoms associated with delay aversion or choice impulsivity? A general population study. J Am Acad Child Adolesc Psychiatry 48: 837-846.
55. Patton JH, Stanford MS, Barratt ES (1995). Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51: 768-774. (Pubitemid 26021724)
56. Paulson RB, Shanfeld J, Vorhees CV, Sweazy A, Gagni S, Smith AR et al (1993). Behavioral effects of prenatally administered smokeless tobacco on rat offspring. Neurotoxicol Teratol 15: 183-192. (Pubitemid 23153881)
57. Pauly JR, Slotkin TA (2008). Maternal tobacco smoking, nicotine replacement and neurobehavioural development. Acta Paediatr 97: 1331-1337.
58. Pauly JR, Sparks JA, Hauser KF, Pauly TH (2004). In utero nicotine exposure causes persistent, gender-dependant changes in locomotor activity and sensitivity to nicotine in C57Bl/6 mice. Int J Dev Neurosci 22: 329-337. (Pubitemid 39233540)
59. Paz R, Barsness B, Martenson T, Tanner D, Allan AM (2007). Behavioral teratogenicity induced by nonforced maternal nicotine consumption. Neuropsychopharmacology 32: 693-699.
60. Peters MA, Ngan LL (1982). The effects of totigestational exposure to nicotine on pre- and postnatal development in the rat. Arch Int Pharmacodyn Ther 257: 155-167. (Pubitemid 12071194)
61. Polanczyk G, De Lima MS, Horta BL, Biederman J, Rohde LA (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164: 942-948. (Pubitemid 46972911)
62. Ribary U, Lichtensteiger W (1989). Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring. J Pharmacol Exp Ther 248: 786-792. (Pubitemid 19091563)
63. Robbins TW (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163: 362-380.
64. Rogers RD, Baunez C, Everitt BJ, Robbins TW (2001). Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance. Behav Neurosci 115: 799-811. (Pubitemid 32738326)
65. Romero RD, Chen WJ (2004). Gender-related response in open-field activity following developmental nicotine exposure in rats. Pharmacol Biochem Behav 78: 675-681. (Pubitemid 39037725)
66. Ross MG, Desai M (2005). Gestational programming: population survival effects of drought and famine during pregnancy. Am J Physiol Regul Integr Comp Physiol 288: R25-R33. (Pubitemid 40023907)
67. Scheres A, Dijkstra M, Ainslie E, Balkan J, Reynolds B, Sonuga-Barke E et al (2006). Temporal and probabilistic discounting of rewards in children and adolescents: effects of age and ADHD symptoms. Neuropsychologia 44: 2092-2103. (Pubitemid 43993990)
68. Sagvolden T, Aase H, Zeiner P, Berger D (1998). Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder. Behav Brain Res 94: 61-71. (Pubitemid 28352465)
69. Schneider T, Bizarro L, Asherson PJN, Stolerman IP (2009). Impulsivity, hyperactivity, enhanced 'risk-taking' behaviour and excessive nicotine consumption in adolescent rats prenatally exposed to nicotine. Behav Pharmacol 20: S21.
70. Schneider T, Bizarro L, Asherson PJN, Stolerman IP (2010). Gestational exposure to nicotine in drinking water: teratogenic effects and methodological issues. Behav Pharmacol 21: 206-216.
71. Shea AK, Steiner M (2008). Cigarette smoking during pregnancy. Nicotine Tob Res 10: 267-278. (Pubitemid 351201310)
72. Slotkin TA (2004). Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol 198: 132-151. (Pubitemid 38960724)
73. Slotkin TA, Lappi SE, McCook EC, Lorber BA, Seidler FJ (1995). Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. Brain Res Bull 38: 69-75.
74. Smith KM, Bauer L, Fischer M, Barkley R, Navia BA (2005). Identification and characterization of human NR4A2 polymorphisms in attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 133B: 57-63. (Pubitemid 40175616)
75. Sorenson CA, Raskin LA, Suh Y (1991). The effects of prenatal nicotine on radial-arm maze performance in rats. Pharmacol Biochem Behav 40: 991-993.
76. Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M et al (2009). Prenatal smoking might not cause attention-deficit/ hyperactivity disorder: evidence from a novel design. Biol Psychiatry 66: 722-727.
77. Tizabi Y, Popke EJ, Rahman MA, Nespor SM, Grunberg NE (1997). Hyperactivity induced by prenatal nicotine exposure is associated with an increase in cortical nicotinic receptors. Pharmacol Biochem Behav 58: 141-146. (Pubitemid 27335454)
78. Uebel H, Albrecht B, Asherson P, Borger NA, Butler L, Chen W et al (2010). Performance variability, impulsivity errors and the impact of incentives as gender-independent endophenotypes for ADHD. J Child Psychol Psychiatry 51: 210-218.
79. Vaglenova J, Birru S, Pandiella NM, Breese CR (2004). An assessment of the long-term developmental and behavioral teratogenicity of prenatal nicotine exposure. Behav Brain Res 150: 159-170. (Pubitemid 38368967)
80. Vaglenova J, Parameshwaran K, Suppiramaniam V, Breese CR, Pandiella N, Birru S (2008). Long-lasting teratogenic effects of nicotine on cognition: gender specificity and role of AMPA receptor function. Neurobiol Learn Mem 90: 527-536.
81. Wada N, Yamashita Y, Matsuishi T, Ohtani Y, Kato H (2000). The test of variables of attention (TOVA) is useful in the diagnosis of Japanese male children with attention deficit hyperactivity disorder. Brain Dev 22: 378-382.
82. Waldman ID, Gizer IR (2006). The genetics of attention deficit hyperactivity disorder. Clin Psychol Rev 26: 396-432.
83. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF (2005). Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 57: 1336-1346. (Pubitemid 40798553)
84. Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, Fossdal R et al (2010). Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 376: 1401.
85. Winstanley CA, Dalley JW, Theobald DE, Robbins TW (2004). Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neurop-sychopharmacology 29: 1331-1343. (Pubitemid 38780656)
86. Winstanley CA, Eagle DM, Robbins TW (2006). Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev 26: 379-395.
87. Winzer-Serhan UH (2008). Long-term consequences of maternal smoking and developmental chronic nicotine exposure. Front Biosci 13: 636-649. (Pubitemid 351599773)